Where does JSG IP Ventures, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), JSG IP Ventures, LLC ranks #36,062 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does JSG IP Ventures, LLC hold?

JSG IP Ventures, LLC holds 7 US utility patents granted between 2023 and 2025, spanning 8 technology areas.

What is JSG IP Ventures, LLC's Innovation Score?

JSG IP Ventures, LLC has an Innovation Score of 44.6 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does JSG IP Ventures, LLC focus on?

JSG IP Ventures, LLC's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 6 patents, ranking #583 of 1,943 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is JSG IP Ventures, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for JSG IP Ventures, LLC.

What does claim depth mean for JSG IP Ventures, LLC's patents?

JSG IP Ventures, LLC's patents average 23.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the JSG IP Ventures, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

JSG IP Ventures, LLC

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, JSG ranks #36,062 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#36,062
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.6/100): 23.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R36062 · US Corporation #36,062 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #36,062/49,997
PHOTO-FINISH Johnny Rhymes With…
CPC-NARROW A61N · 8 areas
INNOV-PAR 44.6/100
CLAIMS-DENSE 23.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Johnny Rhymes With Connie, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How JSG’s 44.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (16%) Velocity 13.3 pts (30%) Breadth 10.0 pts (22%) Claim depth 14.1 pts (32%)

Qualcomm Incorporated · highest

85
Eko Sport · near

45
JSG IP Ventures · this assignee

45
Shukla Medical · near

45
Arla Foods Amba · near

45
Bone Foam · near

45
3D Lighting… · lowest

7

What this shows JSG's Innovation Score is 44.6/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for JSG?

Each dot is one of JSG’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). JSG’s own 23.4 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

JSG vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where JSG's grants concentrate

JSG IP Ventures, LLC is a focused PatentsView assignee: 8 CPC subclasses with 85.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). By volume, JSG sits between Johnny Rhymes With Connie, LLC and Jyant Technologies, Inc..

JSG's three-year grant acceleration

JSG IP Ventures, LLC shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Johnny Rhymes Wit…

7
JPI Healthcare

7
JPS

7
JR Chem

7
Jtekt Automotive…

7
Julius-k9

7
Julius-k9 Zrt

7
Jyant

7
JSG IP Ventures ◀

7

What this shows JSG holds 7 patents at rank #36,017, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near JSG

By rank, the assignees closest to #36,017 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in JSG's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for JSG, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), JSG ranks #583 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Eko Sport, Inc. 45 Shukla Medical 45 Arla Foods Amba 45 Bone Foam, Inc. 45

JSG's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

JSG IP Ventures, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	1	14.3%
2024	1	14.3%
2025partial year	5	71.4%

Which technologies does JSG IP Ventures, LLC patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

A61B - DIAGNOSIS; SURGERY; Identification 4

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

JSG IP Ventures, LLC's patent record in context - here's where to go next.

JSG IP Ventures, LLC's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 85.7% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #36,062 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare JSG IP Ventures, LLC against Johnny Rhymes With Connie, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.